c-Myc, a well-established oncogene in hepatocellular carcinoma cells, has been implicated in promoting various malignant biological behaviors, including tumor development, drug resistance, and immune evasion (Liu et al. 2019; Wang et al. 2023). The gene discussed is MYC; the disease is hepatocellular carcinoma.